WHO puts first molecular test for Bundibugyo virus in Emergency Use Listing: what it means
The World Health Organization has granted Emergency Use Listing to the first molecular diagnostic test for the Bundibugyo virus. This move aims to improve rapid detection of the rare Ebola strain currently causing an outbreak in the Democratic Republic of Congo and Uganda.
Why it matters
The availability of a validated diagnostic tool is critical for managing the current outbreak, which has resulted in hundreds of deaths and poses a significant public health challenge in Central Africa.
On July 2, 2026, the World Health Organization (WHO) announced that it had added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL). The test detects the virus by identifying its genetic material in blood samples, helping confirm infection rapidly and accurately.
The article relies on official WHO data and provides a straightforward report on public health developments.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in